| Name | thrombomodulin |
|---|---|
| Synonyms | CD141; TM; CD141 antigen; Fetomodulin; THBD; THRM; Thrombomodulin; Thrombomodulin precursor… |
| Name | IBA |
|---|---|
| CAS |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 16482045 | Dankovtseva EN, Zateishchikov DA, Sidorenko BA: [Polymorphism of Genes of Factors of Hemostasis in Patients With Early Development of Ischemic Heart Disease.]. Kardiologiia. 2006;45(1):56-65. Information is presented on polymorphisms of tissue factor, coagulation factors VII, V, prothrombin, thrombomodulin, fibrinogen, thrombin activated fibrinolysis inhibitor, tissue plasminogen activator inhibitor, platelet membrane glycoproteines Ia, Iba, IIIa in patients with early development of IHD. |
81(1,1,1,1) | Details |
| 7549268 | Iba T, Yagi Y, Kidokoro A, Fukunaga M, Fukunaga T: Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure. Surg Today. 1995;25(7):585-90. |
2(0,0,0,2) | Details |
| 20003418 | Iba T, Nakarai E, Takayama T, Nakajima K, Sasaoka T, Ohno Y: Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model. Crit Care. 2009;13(6):R203. Epub 2009 Dec 14. |
2(0,0,0,2) | Details |
| 8696988 | Kidokoro A, Iba T, Fukunaga M, Yagi Y: Alterations in coagulation and fibrinolysis during sepsis. . Shock. 1996 Mar;5(3):223-8. Tissue plasminogen activator (t-PA), plasminogen activator inhibitor 1 (PAI-1), and thrombomodulin were also measured. |
2(0,0,0,2) | Details |
| 17993956 | Iba T, Gando S, Murata A, Kushimoto S, Saitoh D, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Ikeda T, Ishhikura H, Ueyama M, Ogura Y, Endo S, Shimazaki S: Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers. J Trauma. 2007 Nov;63(5):1093-8. RESULTS: Significant changes between the groups were observed in platelet count, fibrin or fibrinogen degradation products, interleukin-6, soluble thrombomodulin, antithrombin (AT) activity, and protein C activity, both on day 0 and on day 2. |
1(0,0,0,1) | Details |